セフメノキシム塩酸塩
セフメノキシム塩酸塩 物理性質
- 融点 :
- >175°C (dec.)
- 貯蔵温度 :
- under inert gas (nitrogen or Argon) at 2-8°C
- 溶解性:
- DMSO（微量、加熱）、メタノール（微量）
- 外見 :
- 個体
- 色:
- オフホワイトからペールイエロー
- InChIKey:
- HZYJYGJIOCXOTH-AJVJENPNNA-N
- SMILES:
- C(C1=C(CS[C@]2([H])[C@H](NC(=O)/C(/C3N=C(N)SC=3)=N\OC)C(=O)N12)CSC1=NN=NN1C)(=O)O.Cl |&1:5,7,r|
セフメノキシム塩酸塩 価格
もっと(6)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242835 |
セフメノキシム塩酸塩
Cefmenoxime Hydrochloride |
75738-58-8 |
50mg |
￥34800 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242835 |
セフメノキシム塩酸塩
Cefmenoxime Hydrochloride |
75738-58-8 |
100mg |
￥56400 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242835 |
セフメノキシム塩酸塩
Cefmenoxime Hydrochloride |
75738-58-8 |
250mg |
￥112200 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242835 |
セフメノキシム塩酸塩
Cefmenoxime Hydrochloride |
75738-58-8 |
500mg |
￥180400 |
2023-06-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01TRCC242835 |
セフメノキシム塩酸塩
Cefmenoxime Hydrochloride |
75738-58-8 |
1g |
￥339100 |
2023-06-01 |
購入 |
セフメノキシム塩酸塩 化学特性,用途語,生産方法
効能
抗生物質, 細胞壁合成阻害薬
商品名
ベストコール (武田テバ薬品); ベストコール (武田テバ薬品); ベストロン (千寿製薬); ベストロン (千寿製薬); ベストロン (千寿製薬)
説明
Cef menoxime hydrochloride is a third generation cephalosporin antibiotic.
Structurally, it possesses the (1-methyl-lH-tetrazol-5-yl)thiomethyl moiety in
the 3-position; like several other compounds containing this structural element
(moxalactam, cefoperazone, cefamandol), bleeding linked to vitamin K interaction
has been reported. Cefmenoxime has activity similar to cefotiuime, ceftizoxime
and moxalactam against E.coli, C. diversus, Klebsiella, P. Mirabilis, Salmonella,
Shigella, Neiseria spp., S. pyogenes, S. Pneumoniae, and g. influenzae. It is
relatively ineffective against Pseudomonas and Bacteroidea.
使用
A third generation cephalosporin antibiotic with strong antimicrobial activities against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella subgenus Branhamella catarrhalis that were 3 major aerobic bacteria from sinusitis.
定義
ChEBI: The hemihydrochloride salt of cefmenoxime.
一般的な説明
Cefmenoxime was synthesized by Takeda Pharmaceutical Co. in 1978. It contains aminothiazole and methoxyimino groups in the 7-acyl position and a methyltetrazole group at the 3 position of the cephem nucleus. Cefmenoxime has a wide activity spectrum against gram-positive and gram-negative bacteria, including anaerobes, except Staphylococcus aureus. Cefmenoxime is a member of the so-called third-generation cephalosporins, a recently introduced class of clinically important antibiotics.
セフメノキシム塩酸塩 上流と下流の製品情報
原材料
準備製品
セフメノキシム塩酸塩 生産企業
Global( 177)Suppliers
75738-58-8(セフメノキシム塩酸塩)キーワード:
- 75738-58-8
- 8-[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino-4-[(1-methyltetrazol-5-yl)sulfanylmethyl]-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid hydrochloride (2:1)
- 7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hemihydrochloride
- 7beta-[2-(2-Aminothiazol-4-yl)-(Z)-2-(methoxyiminoacetamido)]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]ceph-3-em-4-carboxylic acid hemihydrochloride
- Bestcall
- Bestron
- Cemix
- SCE-1365(free acid)
- Tacef
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, hydrochloride (2:1), [6R-[6α,7β(Z)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, hydrochloride (2:1), (6R,7R)-
- Abbott 50192
- Cefmax
- )(methoxyimino)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-ox
- ab50912hemihydrochloride
- cefmenoximehemihydrochloride
- hydrochloride(2:1),(6r-(6-alpha,7-beta(z)))-o
- sce1365hydrochloride
- CEFMENOXIME HCL
- CEFMENOXIME HYDROCHLORIDE
- (6R)-7α-[[(2-Amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-3-[[(1-methyl-1H-tetrazole-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid·0.5hydrochloride
- 2Cefmenoxime·Hydrochloride
- Cefmenoxime Hydrochloride (350 mg)
- CefMenoxiMe SodiuM
- (6R,7R)-7-[[(2Z)-(2-AMino-4-thiazolyl)(MethoxyiMino)acetyl]aMino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid HeMihydrochloride
- CefMenoxiMe HCL Sterile (pure)
- Hydrochloride (syn-isomer)
- 7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride
- CEFMENOXIME HEMIHYDROCHLORIDE;SCE-1365 HEMIHYDROCHLORIDE
- SCE-1365 hemihydrochloride
- (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride(2:1)
- ベストコール
- 塩酸セフメノキシム
- (6R)-7α-[[(2-アミノ-4-チアゾリル)[(Z)-メトキシイミノ]アセチル]アミノ]-3-[[(1-メチル-1H-テトラゾール-5-イル)チオ]メチル]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸·0.5塩酸塩
- ベストロン
- セフメノキシム塩酸塩
- 2セフメノキシム·塩酸塩
- セフメノキシム塩酸塩 (JP17)
- (6R)-7α-[[(2-アミノ-4-チアゾリル)[(Z)-メトキシイミノ]アセチル]アミノ]-3-[[(1-メチル-1H-テトラゾール-5-イル)チオ]メチル]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸・0.5塩酸塩
- 2セフメノキシム・塩酸塩
- セファロスポリン類